These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31163016)

  • 1. Strategies Used by Adults Aged 65 and Over to Reduce Their Prescription Drug Costs, 2016-2017.
    Cohen RA; Boersma P
    NCHS Data Brief; 2019 May; (335):1-8. PubMed ID: 31163016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies used by adults to reduce their prescription drug costs.
    Cohen RA; Kirzinger WK; Gindi RM
    NCHS Data Brief; 2013 Apr; (119):1-8. PubMed ID: 23742848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies used by adults to reduce their prescription drug costs: United States, 2013.
    Cohen RA; Villarroel MA
    NCHS Data Brief; 2015 Jan; (184):1-8. PubMed ID: 25633356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015.
    Tang W; Xie J; Kong F; Malone DC
    Value Health; 2019 Aug; 22(8):871-877. PubMed ID: 31426927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies Used by Adults Aged 18-64 to Reduce Their Prescription Drug Costs, 2017.
    Cohen RA; Boersma P; Vahratian A
    NCHS Data Brief; 2019 Mar; (333):1-8. PubMed ID: 31112124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Americans' access to prescription drugs stabilizes, 2007-2010.
    Boukus ER; Carrier ER
    Track Rep; 2011 Dec; (27):1-5. PubMed ID: 22180943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems due to medication costs among VA and non-VA patients with chronic illnesses.
    Piette JD; Heisler M
    Am J Manag Care; 2004 Nov; 10(11 Pt 2):861-8. PubMed ID: 15609740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to prescription drugs for Medicare beneficiaries.
    Reschovsky JD; Felland LE
    Track Rep; 2009 Mar; (23):1-4. PubMed ID: 19320086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription drug coverage among elderly and disabled Americans: can Medicare-Part D reduce inequities in access?
    Kanavos P; Gemmill-Toyama M
    Int J Health Care Finance Econ; 2010 Sep; 10(3):203-18. PubMed ID: 20213234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.
    Polinski JM; Brookhart MA; Glynn RJ; Schneeweiss S
    J Clin Psychopharmacol; 2012 Feb; 32(1):3-10. PubMed ID: 22198455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population.
    Musich S; Cheng Y; Wang SS; Hommer CE; Hawkins K; Yeh CS
    J Gen Intern Med; 2015 Aug; 30(8):1208-14. PubMed ID: 25666213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting access and reducing expected out-of-pocket prescription drug costs for vulnerable Medicare beneficiaries: a pharmacist-directed model.
    Cutler TW; Stebbins MR; Smith AR; Patel RA; Lipton HL
    Med Care; 2011 Apr; 49(4):343-7. PubMed ID: 21407030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Medicare Part D and insurance type on Medicare beneficiary access to prescription medication and use of prescription cost-saving measures.
    Urmie JM; Farris KB; Doucette WR; Goedken AM
    J Am Pharm Assoc (2003); 2011; 51(1):72-81. PubMed ID: 21247829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies Used by Adults With Diagnosed Diabetes to Reduce Their Prescription Drug Costs, 2017-2018.
    Cohen RA; Cha AE
    NCHS Data Brief; 2019 Aug; (349):1-8. PubMed ID: 31442199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Medicare Part D Prescription Drug Plans and Medication Adherence: A Conceptual Framework and Empirical Analysis.
    Young GJ; Rickles NM; Benzer JK; Dangi A
    Med Care; 2017 Jan; 55(1):37-42. PubMed ID: 27547952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the accuracy of MEPS prescription drug data for health services research.
    Hill SC; Zuvekas SH; Zodet MW
    Inquiry; 2011; 48(3):242-59. PubMed ID: 22235548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.